The high stage (stage IV) subgroup showed a significantly shorter median progression-free survival time than the lower stage (stage I-III) subgroup (35.1 vs. 54.3 months; p = 0.015).
- Kazuhiro Kitajima (562836)
- Yuko Suenaga (562837)
- Tomonori Kanda (562838)
- Daisuke Miyawaki (562839)
- Kenji Yoshida (299416)
- Yasuo Ejima (562840)
- Ryohei Sasaki (562841)
- Hirokazu Komatsu (209445)
- Miki Saito (562842)
- Naoki Otsuki (562843)
- Ken-ichi Nibu (562844)
- Naomi Kiyota (562845)
- Tsutomu Minamikawa (562846)
- Kazuro Sugimura (462833)
Publication date
May 2014
DOIAbstract
<p>The high stage (stage IV) subgroup showed a significantly shorter median progression-free survival time than the lower stage (stage I-III) subgroup (35.1 vs. 54.3 months; p = 0.015).</p
Add to ORKG